Quest Diagnostics DGX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 132.7%+0.4pp | 132.4%+0.4pp | 132%+0.6pp | 131.5%+0.2pp | 131.2%0.0pp | |
| Operating margin | 56.5%+0.6pp | 55.9%+0.5pp | 55.5%+1.0pp | 54.5%+0.5pp | 54%+0.2pp | |
| Net margin | 36%+0.2pp | 35.8%+0.2pp | 35.6%+0.1pp | 35.5%0.0pp | 35.5%-0.3pp | |
| EBITDA margin | 77.1%+0.6pp | 76.5%+0.6pp | 75.9%+1.3pp | 74.6%+0.8pp | 73.8%+0.4pp | |
| Free cash flow margin | 48.5%+1.4pp | 47.2%+3.1pp | 44.1%+2.1pp | 42%+2.3pp | 39.7%+0.2pp | |
| Returns | ||||||
| Return on equity | 56.1%+0.9pp | 55.2%+0.9pp | 54.2%+1.1pp | 53.2%+0.7pp | 52.5%-0.1pp | |
| Return on assets | 24.8%+0.3pp | 24.5%+0.4pp | 24.2%+0.3pp | 23.9%+0.2pp | 23.6%-0.3pp | |
| Return on invested capital | 36.3%+0.4pp | 35.9%+0.5pp | 35.4%+0.9pp | 34.6%+0.5pp | 34.1%-0.2pp | |
| Efficiency | ||||||
| Asset turnover | 2.8×0.0× | 2.7×0.0× | 2.7×0.0× | 2.7×0.0× | 2.7×0.0× | |
| Inventory turnover | 152.8×-0.5× | 153.3×+4.0× | 149.3×+4.2× | 145×+3.9× | 141.1×+3.3× | |
| Liquidity | ||||||
| Current ratio | 4.4×-0.3× | 4.7×-0.1× | 4.8×-0.1× | 4.9×+0.1× | 4.8×+0.5× | |
| Quick ratio | 4.1×-0.2× | 4.3×-0.1× | 4.4×-0.1× | 4.5×+0.1× | 4.4×+0.4× | |
| Cash ratio | 0.7×0.0× | 0.7×-0.1× | 0.7×-0.2× | 0.9×0.0× | 0.9×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 3.5×-0.1× | 3.6×-0.1× | 3.7×-0.1× | 3.9×+0.1× | 3.8×+0.1× | |
| Debt-to-assets | 1.6×0.0× | 1.6×0.0× | 1.6×0.0× | 1.7×0.0× | 1.6×0.0× | |
| Net debt / EBITDA | 11.4×-0.6× | 12×-0.7× | 12.7×-0.8× | 13.4×+0.2× | 13.2×+0.5× | |
| Valuation | ||||||
| Market capitalization | $82.23B+3.5% | $79.48B+3.2% | $77.01B+5.5% | $72.98B+7.2% | $68.1B+6.3% | |
| Enterprise value | $106.24B+2.3% | $103.86B+2.0% | $101.8B+3.8% | $98.03B+6.7% | $91.9B+6.4% | |
| Price / earnings | 83.6×+0.1× | 83.5×+0.1× | 83.4×+1.4× | 82×+3.0× | 78.9×+3.5× | |
| Price / sales | 7.5×+0.1× | 7.5×0.0× | 7.4×+0.2× | 7.3×+0.3× | 7×+0.3× | |
| Price / book | 11.3×+0.2× | 11.1×+0.2× | 10.9×+0.4× | 10.5×+0.5× | 10×+0.4× | |
| EV / EBITDA | 50.5×-0.6× | 51.1×-0.7× | 51.8×-0.6× | 52.4×+1.3× | 51.1×+1.7× | |
| EV / sales | 9.7×0.0× | 9.8×-0.1× | 9.8×+0.1× | 9.8×+0.3× | 9.4×+0.4× | |
| Free cash flow yield | 25.8%+0.5pp | 25.3%+1.6pp | 23.7%+0.6pp | 23%+0.3pp | 22.7%-0.8pp | |
| Earnings yield | 19.2%0.0pp | 19.2%0.0pp | 19.2%-0.3pp | 19.5%-0.8pp | 20.3%-1.0pp | |
| Dividend yield | 6.8%-0.1pp | 6.9%-0.1pp | 7.1%-0.3pp | 7.4%-0.4pp | 7.8%-0.4pp | |
| PEG ratio | 5.9×-2.0× | 7.9×-8.3× | 16.2×-0.6× | 16.8×-1.5× | 18.3×+0.9× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Quest Diagnostics's profit margins?
- Quest Diagnostics (DGX) runs a 33.2% gross margin and a 14.3% operating margin, with a 9.1% net margin.
- Where do Quest Diagnostics's ratios come from?
- Every ratio is computed from Quest Diagnostics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
